<DOC>
	<DOCNO>NCT01601470</DOCNO>
	<brief_summary>This study conduct investigate potential pharmacokinetic drug-drug interaction support co-administration LCZ696 sildenafil .</brief_summary>
	<brief_title>Evaluation Drug-drug Interaction Between LCZ696 Sildenafil Subjects With Mild Moderate Hypertension</brief_title>
	<detailed_description>This study conduct investigate potential pharmacokinetic drug-drug interaction patient mild-to-moderate hypertension support co-administration LCZ696 sildenafil .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Male subject mild moderate hypertension , either treat currently treatment , age 18 65 year age , otherwise good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen . At screening : systolic blood pressure 120140 mmHg therapy , 140160 mmHg untreated At screening : diastolic blood pressure , 7095 mmHg therapy , 90100 mmHg untreated Baseline : BP â‰¥140/90 ; Use nonantihypertensive prescription drug , herbal supplement , and/or overthecounter ( OTC ) medication , dietary supplement ( vitamin include ) within two ( 2 ) week prior initial dose Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>LCZ696 , sildenafil , pharmacokinetics , mild moderate hypertension</keyword>
</DOC>